Therapies are currently available for relapsing-remitting MS, secondary progressive MS and progressive relapsing MS.
目前有针对复发-缓解型，继发-进展型，与进展-复发型多发硬化症的治疗方案。
Relapsing-remitting multiple sclerosis is an inflammatory demyelinating disease of the CNS that is presumed to have an autoimmune cause.
复发缓和多发性硬化是一种炎性中枢系统脱髓鞘疾病，推测由自身免疫引起。
They can reduce the incidence of relapse or extend time between relapses in the relapsing-remitting form of MS but symptoms are not changed by the drugs.
它们能够降低医学倒退的发生率或者延缓倒退-抵消相转换的医学形式，但是，药物并不能够改变这些症候。
The most common type is relapsing-remitting MS, in which patients experience attacks of symptoms such as muscle weakness and spasms followed by periods of symptom-free remission.
最常见的类型是“复发-缓解型多发性硬化”，即病人在症状发作后，如肌无力和肌痉挛，有一段症状完全缓解的期间。
The most common type is relapsing-remitting MS, in which patients experience attacks of symptoms such as muscle weakness and spasms followed by periods of symptom-free remission.
最常见的类型是“复发-缓解型多发性硬化”，即病人在症状发作后，如肌无力和肌痉挛，有一段症状完全缓解的期间。
应用推荐